Motor complications, wearing off, delayed on and dyskinesias, are more prevalent in GBA1-PD, especially in those harbouring severe mutations, and occur earlier than in GBA1 mutation-negative PD patients (Jesus et al. 2016; Zhang et al. 2018b). This evidence concerns the gene GBA1 and drug-induced dyskinesia.